TheProductLawyers.com reports on the numbers of Xarelto lawsuits that have been consolidated together because of the uniformity of the allegations being made about the drug's dangerous side effects. All plaintiffs are claiming that Xarelto may place patients using the drug at a much higher risk for dangerous and life-threatening instances of uncontrollable bleeding, as well as other adverse impacts. The consolidated cases also share the same defendants, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer AG.
There are currently two groups of consolidated cases. The first is a mass tort program in Philadelphia, PA that was completed under the direction of the Court of Common Pleas. There are 550 cases in this tort program and there may be a possibility of more lawsuits being filed.
The second group of cases number over 2,800 and were consolidated into a Multidistrict Litigation (MDL) with a decree made by the U.S. Judicial Panel for Multidistrict Litigation (JPML) and has been assigned number 2592. The cases are being overseen and administered in a federal court in the Eastern District of Louisiana. Plaintiffs in all of the cases in the multidistrict litigation (MDL) concur that the manufacturers of Xarelto were negligent and reckless in releasing Xarelto onto the market without fully disclosing the nature of the potentially dangerous risks associated with the drug.
Xarelto has also been the recipient of two black box warnings by the U.S. Food and Drug Administration (FDA). A black box warning is the most severe warning that can be issued by the FDA and can frequently be a precursor to a drug being pulled from the market.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.
TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.
165 West End Ave #1h,
New York, NY 10023
November 30, 2016 – Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb
November 30, 2016 – Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings
November 30, 2016 – J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit
November 30, 2016 – Delaware Sees 10 New Talcum Powder Lawsuit Filings
November 29, 2016 – Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed
November 29, 2016 – Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother
November 29, 2016 – Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue
November 28, 2016 – FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings
November 28, 2016 – Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings
November 28, 2016 – More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts